139 related articles for article (PubMed ID: 34001746)
1. Clinical and Histopathologic Characteristics of Metastatic and Locally Advanced Cutaneous Basal Cell Carcinomas.
Baker LX; Grilletta E; Zwerner JP; Boyd AS; Wheless L
Am J Dermatopathol; 2021 Dec; 43(12):e169-e174. PubMed ID: 34001746
[TBL] [Abstract][Full Text] [Related]
2. Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study.
Sekulic A; Migden MR; Basset-Seguin N; Garbe C; Gesierich A; Lao CD; Miller C; Mortier L; Murrell DF; Hamid O; Quevedo JF; Hou J; McKenna E; Dimier N; Williams S; Schadendorf D; Hauschild A;
BMC Cancer; 2017 May; 17(1):332. PubMed ID: 28511673
[TBL] [Abstract][Full Text] [Related]
3. Basosquamous carcinoma and metatypical basal cell carcinoma: a review of treatment with Mohs micrographic surgery.
Allen KJ; Cappel MA; Killian JM; Brewer JD
Int J Dermatol; 2014 Nov; 53(11):1395-403. PubMed ID: 24961583
[TBL] [Abstract][Full Text] [Related]
4. Metastatic basal cell carcinoma. Report of five cases.
Snow SN; Sahl W; Lo JS; Mohs FE; Warner T; Dekkinga JA; Feyzi J
Cancer; 1994 Jan; 73(2):328-35. PubMed ID: 8293396
[TBL] [Abstract][Full Text] [Related]
5. Cemiplimab for locally advanced and metastatic basal cell carcinoma.
Damsin T; Lebas E; Marchal N; Rorive A; Nikkels AF
Expert Rev Anticancer Ther; 2022 Mar; 22(3):243-248. PubMed ID: 35175882
[TBL] [Abstract][Full Text] [Related]
6. Hedgehog Pathway Inhibitor Therapy for Locally Advanced and Metastatic Basal Cell Carcinoma: A Systematic Review and Pooled Analysis of Interventional Studies.
Jacobsen AA; Aldahan AS; Hughes OB; Shah VV; Strasswimmer J
JAMA Dermatol; 2016 Jul; 152(7):816-24. PubMed ID: 27096888
[TBL] [Abstract][Full Text] [Related]
7. Metastatic basal cell carcinoma: report of two cases and literature review.
Ting PT; Kasper R; Arlette JP
J Cutan Med Surg; 2005 Jan; 9(1):10-5. PubMed ID: 16208438
[TBL] [Abstract][Full Text] [Related]
8. The incidence of metastatic basal cell carcinoma (mBCC) in Denmark, 1997-2010.
Nguyen-Nielsen M; Wang L; Pedersen L; Olesen AB; Hou J; Mackey H; McCusker M; Basset-Seguin N; Fryzek J; Vyberg M
Eur J Dermatol; 2015; 25(5):463-8. PubMed ID: 26105129
[TBL] [Abstract][Full Text] [Related]
9. Which features of advanced head and neck basal cell carcinoma are associated with perineural invasion?
Santos AB; Andrade NM; Brandão LG; Cernea CR
Braz J Otorhinolaryngol; 2017; 83(1):94-97. PubMed ID: 27160472
[TBL] [Abstract][Full Text] [Related]
10. Metastatic basal cell carcinoma in the era of hedgehog signaling pathway inhibitors.
Weiss GJ; Korn RL
Cancer; 2012 Nov; 118(21):5310-9. PubMed ID: 22511370
[TBL] [Abstract][Full Text] [Related]
11. Efficacy, rate of tumor response, and safety of a short course (12-24 weeks) of oral vismodegib in various histologic subtypes (infiltrative, nodular, and superficial) of high-risk or locally advanced basal cell carcinoma, in an open-label, prospective case series clinical trial.
Fosko SW; Chu MB; Armbrecht E; Galperin T; Potts GA; Mattox A; Kurta A; Polito K; Slutsky JB; Burkemper NM; Hurley MY
J Am Acad Dermatol; 2020 Apr; 82(4):946-954. PubMed ID: 31836564
[TBL] [Abstract][Full Text] [Related]
12. Incidence and prevalence of basal cell carcinoma (BCC) and locally advanced BCC (LABCC) in a large commercially insured population in the United States: A retrospective cohort study.
Goldenberg G; Karagiannis T; Palmer JB; Lotya J; O'Neill C; Kisa R; Herrera V; Siegel DM
J Am Acad Dermatol; 2016 Nov; 75(5):957-966.e2. PubMed ID: 27473450
[TBL] [Abstract][Full Text] [Related]
13. Does the panel of cytokeratin 20 and androgen receptor antibodies differentiate desmoplastic trichoepithelioma from morpheaform/infiltrative basal cell carcinoma?
Katona TM; Perkins SM; Billings SD
J Cutan Pathol; 2008 Feb; 35(2):174-9. PubMed ID: 18190441
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous basal cell carcinoma with distant metastasis to thorax and bone : A clinicopathological and immunohistochemical study of 15 cases.
Weissferdt A; Kalhor N; Moran CA
Virchows Arch; 2017 Jun; 470(6):687-694. PubMed ID: 28391557
[TBL] [Abstract][Full Text] [Related]
15. Micronodular basal cell carcinoma: a distinct subtype? Relationship with nodular and infiltrative basal cell carcinomas.
Betti R; Menni S; Radaelli G; Bombonato C; Crosti C
J Dermatol; 2010 Jul; 37(7):611-6. PubMed ID: 20629826
[TBL] [Abstract][Full Text] [Related]
16. Basal cell carcinoma of the eyelids and periorbital region in a Turkish population.
Soysal HG; Soysal E; Markoç F; Ardiç F
Ophthalmic Plast Reconstr Surg; 2008; 24(3):201-6. PubMed ID: 18520835
[TBL] [Abstract][Full Text] [Related]
17. Incidence of perineural invasion in histologically aggressive types of basal cell carcinoma.
Brown CI; Perry AE
Am J Dermatopathol; 2000 Apr; 22(2):123-5. PubMed ID: 10770431
[TBL] [Abstract][Full Text] [Related]
18. Vismodegib and Sonidegib in Locally Advanced and Metastatic Basal Cell Carcinoma: Update on Hedgehog Pathway Inhibitors.
Kurnia Wijaya J; Djawad K; Wahab S; Nurdin A; Irawan Anwar A
Actas Dermosifiliogr; 2022 May; 113(5):443-450. PubMed ID: 35697404
[TBL] [Abstract][Full Text] [Related]
19. Metastatic basal cell carcinoma: prognosis dependent on anatomic site and spread of disease.
McCusker M; Basset-Seguin N; Dummer R; Lewis K; Schadendorf D; Sekulic A; Hou J; Wang L; Yue H; Hauschild A
Eur J Cancer; 2014 Mar; 50(4):774-83. PubMed ID: 24412051
[TBL] [Abstract][Full Text] [Related]
20. Does Immunohistochemistry Add to Morphology in Differentiating Trichoepithelioma, Desmoplastic Trichoepithelioma, Morpheaform Basal Cell Carcinoma, and Microcystic Adnexal Carcinoma?
Mohanty SK; Sardana R; McFall M; Pradhan D; Usmani A; Jha S; Mishra SK; Sampat NY; Lobo A; Wu JM; Balzer BL; Frishberg DP
Appl Immunohistochem Mol Morphol; 2022 Apr; 30(4):273-277. PubMed ID: 35384877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
